MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 7, 2007; DOI: 10.1124/mol.107.040733


0026-895X/08/7302-369-378$20.00
Mol Pharmacol 73:369-378, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.040733v1
73/2/369    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Zou, S.
Right arrow Articles by Dryer, S. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zou, S.
Right arrow Articles by Dryer, S. E.

The β1 Subunit of L-Type Voltage-Gated Ca2+ Channels Independently Binds to and Inhibits the Gating of Large-Conductance Ca2+-Activated K+ Channels

Shengwei Zou, Smita Jha, Eun Young Kim, and Stuart E. Dryer

Department of Biology and Biochemistry, University of Houston, Houston, Texas

Large-conductance Ca2+-activated K+ (BKCa) channels encoded by the Slo1 gene are ubiquitously expressed, and they play a role in regulation of many cell types. In excitable cells, BKCa channels and voltage-activated Ca2+ channels often form functional complexes that allow the cytoplasmic domains of BKCa channels to lie within spatially discrete calcium microdomains. Here, we report a novel protein interaction between the β1-subunit of L-type voltage-activated calcium channels (Cavβ1) and critical regulatory domains of Slo1 that can occur in the absence of other proteins. This interaction was identified by a yeast two-hybrid screen, and it was confirmed by confocal microscopy in native neurons, by coimmunoprecipitation, and by direct binding assays. The Cavβ1 subunit binds within the calcium bowl domain of Slo1 that mediates a portion of high-affinity Ca2+ binding to BKCa channels and also to a noncanonical Src homology 3 (SH3) domain-binding motif within Slo1. Binding of Cavβ1 markedly slows Slo1 activation kinetics, and it causes a significant decrease in Ca2+ sensitivity in inside-out and in dialyzed cells, even in the absence of pore-forming subunits of voltage-gated Ca2+ channels. The guanylate kinase domain of Cavβ1 mediates Slo1 regulation through its binding to calcium bowl domains, and this domain of Cavβ1 is necessary and sufficient for the observed effects on BKCa activation. Binding of Cavβ1 to SH3-binding motifs may stabilize the interaction with Slo1, or it may contribute to formation of other complexes, but it does not seem to affect Ca2+-dependent gating of Slo1. Binding of Cavβ1 does not affect cell surface expression of Slo1 in human embryonic kidney 293T cells.


Received August 8, 2007; accepted November 7, 2007

Address correspondence to: Dr. Stuart E. Dryer, Department of Biology and Biochemistry, University of Houston, 4800 Calhoun, Houston, TX 77204-5001. E-mail: sdryer{at}uh.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics